Daewoong, Boehringer Ingeheim Korea sign strategic partnership agreement
Published: 2010-03-18 06:57:00
Updated: 2010-03-18 06:57:00
Daewoong Pharm and Boehringer Ingeheim Korea (BIK) announced on March 15 that the two companies have signed a strategic partnership agreement to let Daewoong market BIK’s seven leading OTC (over-the-counter) drugs in the domestic market.
These products include Dulcolax, Dulcolax Balance, Busco...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
